Today's Updates

First-Line T-DXd Boosts PFS in HER2-Mutant NSCLC
Published Date: 16 Sep 2026

DESTINY-Lung04 supports trastuzumab deruxtecan as a new frontline option for patients with advanced HER2-mutant disease, though it failed to improve overall survival.

Read More
Could Burnout Become the Employer’s Responsibility?
Published Date: 16 Sep 2026

A European Parliament committee is backing employer risk assessments to tackle burnout. But should that mean new binding EU rules?

Read More
High CLL Remission Seen With First-Line Triplet Regimen
Published Date: 16 Sep 2026

High 2-year survival rates are seen in treatment-naive patients with CLL receiving a noncovalent BTK inhibitor combined with venetoclax and obinutuzumab.

Read More
FET-PET Agent Approved for Glioma Imaging
Published Date: 16 Sep 2026

Floretyrosine F18 is the first amino acid PET imaging agent approved for glioma in the United States.

Read More

Latest News

No Racial Differences Appear in Common COPD Scores

Results support the need for attention to social determinants of health and health system disparities.

COPD and Heart Disease Demand Integrated Clinical Care

Failing to look beyond spirometry in COPD costs lives. Experts at ERS 2026 present new clinical guidance to unify cardiovascular and respiratory management.

Roivant's Experimental Lung Disease Drug Meets Goals in Mid-stage Study

Roivant said on Tuesday its experimental drug met the main goals of a mid-stage study in patients ⁠with high blood pressure associated with a type of lung disease, sending...

Shared Decision-Making in Pediatric Lung Care

Effective communication, empathy amid medical uncertainty, and structured transition plans improve pediatric pulmonary care and the transition to adult care.

Advances in Care for Rare Pediatric Lung Diseases

Living with a rare lung condition can be especially challenging, but research into interogran cross talk and organoid models, and cross-border registry are improving outcomes.

US CDC Records More Than 3,100 Measles Cases So Far in 2026

The U.S. Centers for Disease Control and Prevention said on Friday there were 3,134 confirmed measles ⁠cases in the country so far this year, marking the highest annual...

Holistic Care Must Be Standard in Lung Disease

Experts at ERS 2026 urge clinicians to treat the whole person rather than just damaged lungs, moving from mere symptom control to focus on what matters most to each patient.

CPAP May Offer Enhanced BP Benefit in Sleep Apnea & Insomnia

Patients with both insomnia and obstructive sleep apnea may represent a clinical phenotype characterized by an enhanced systolic BP-lowering response to continuous positive airway pressure therapy.

Australia Confirms First H5N1 Bird Flu Case in Local Mammal

Australia on Sunday confirmed its first case of H5N1 bird flu in a mammal, with the deadly virus ⁠found in a long-nosed fur seal in South Australia state.

Nerandomilast Lowers Mortality Risk in Pulmonary Fibrosis

Nerandomilast is associated with reduced mortality risk in patients with pulmonary fibrosis, a pooled analysis of two trials shows.

Mastering the HER2 Spectrum for Individualized Management of Advanced/Metastatic NSCLC

Mastering the HER2 Spectrum for Individualized Management of Advanced/Metastatic NSCLC

Treating Advanced Disease With Bispecific ADCs: Mechanisms of Action and Therapeutic Rationale for Bispecific ADCs in Solid Tumors

Treating Advanced Disease With Bispecific ADCs: Mechanisms of Action and Therapeutic Rationale for Bispecific ADCs in Solid Tumors

Expert Insights on the Next Wave of IO Combinations in mNSCLC

Expert Insights on the Next Wave of IO Combinations in mNSCLC

New GLP-1 Concern; FDA Sued by Health Groups; Over 750 Dead in Ebola Outbreak

Health news and commentary gathered by MedPage Today staff

Wildfires Expose Millions in the Midwest and Northeast U.S. to Dangerous Smoke

States warned residents about air quality issues that could last for days

Nerve Stimulation for Sleep Apnea Linked to Some Long-Term Heart Benefits

But the higher risk of hypertension and cardiovascular events within 2 years was unexpected

Latest News

No Racial Differences Appear in Common COPD Scores

Results support the need for attention to social determinants of health and health system disparities.

COPD and Heart Disease Demand Integrated Clinical Care

Failing to look beyond spirometry in COPD costs lives. Experts at ERS 2026 present new clinical guidance to unify cardiovascular and respiratory management.

Roivant's Experimental Lung Disease Drug Meets Goals in Mid-stage Study

Roivant said on Tuesday its experimental drug met the main goals of a mid-stage study in patients ⁠with high blood pressure associated with a type of lung disease, sending...

Shared Decision-Making in Pediatric Lung Care

Effective communication, empathy amid medical uncertainty, and structured transition plans improve pediatric pulmonary care and the transition to adult care.

Advances in Care for Rare Pediatric Lung Diseases

Living with a rare lung condition can be especially challenging, but research into interogran cross talk and organoid models, and cross-border registry are improving outcomes.

US CDC Records More Than 3,100 Measles Cases So Far in 2026

The U.S. Centers for Disease Control and Prevention said on Friday there were 3,134 confirmed measles ⁠cases in the country so far this year, marking the highest annual...

Holistic Care Must Be Standard in Lung Disease

Experts at ERS 2026 urge clinicians to treat the whole person rather than just damaged lungs, moving from mere symptom control to focus on what matters most to each patient.

CPAP May Offer Enhanced BP Benefit in Sleep Apnea & Insomnia

Patients with both insomnia and obstructive sleep apnea may represent a clinical phenotype characterized by an enhanced systolic BP-lowering response to continuous positive airway pressure therapy.

Australia Confirms First H5N1 Bird Flu Case in Local Mammal

Australia on Sunday confirmed its first case of H5N1 bird flu in a mammal, with the deadly virus ⁠found in a long-nosed fur seal in South Australia state.

Nerandomilast Lowers Mortality Risk in Pulmonary Fibrosis

Nerandomilast is associated with reduced mortality risk in patients with pulmonary fibrosis, a pooled analysis of two trials shows.

Mastering the HER2 Spectrum for Individualized Management of Advanced/Metastatic NSCLC

Mastering the HER2 Spectrum for Individualized Management of Advanced/Metastatic NSCLC

Treating Advanced Disease With Bispecific ADCs: Mechanisms of Action and Therapeutic Rationale for Bispecific ADCs in Solid Tumors

Treating Advanced Disease With Bispecific ADCs: Mechanisms of Action and Therapeutic Rationale for Bispecific ADCs in Solid Tumors

Expert Insights on the Next Wave of IO Combinations in mNSCLC

Expert Insights on the Next Wave of IO Combinations in mNSCLC

New GLP-1 Concern; FDA Sued by Health Groups; Over 750 Dead in Ebola Outbreak

Health news and commentary gathered by MedPage Today staff

Wildfires Expose Millions in the Midwest and Northeast U.S. to Dangerous Smoke

States warned residents about air quality issues that could last for days

Nerve Stimulation for Sleep Apnea Linked to Some Long-Term Heart Benefits

But the higher risk of hypertension and cardiovascular events within 2 years was unexpected

News All Time

Wildfire Smoke Kills Tens of Thousands Each Year. Here's How It Attacks the Body.

"It's a big giant toxic soup of particles and gases," expert says

FDA Greenlights Next-Generation ROS1 Inhibitor for Lung Cancer

Zidesamtinib is indicated for patients who received a prior ROS1 inhibitor

Reproductive Health Should Be Emphasized in Cystic Fibrosis Care, Foundation Says

Clinicians should initiate annual discussions

Novel Antifungal Shows Activity in Valley Fever

Three-quarters of patients had a clinical response in mid-stage study

CDC Suggests Threat of Mold-Associated Illnesses May Be Underappreciated

"It's kind of the first time we've had an estimate like this," the study's senior author says

FDA Approves First mRNA Flu Vaccine

Approval is for people 50 years or older

Dirty Air Worsens Rheumatoid Arthritis Outcomes, Study Shows

Small particulate matter seen as the main culprit

Senators Pan Trump Officials' Demand for Health Data as Condition for Lifesaving Aid

"These new demands set an alarming precedent," Democratic senators noted

Real-World Study Backs Mepolizumab in Rhinosinusitis With Nasal Polyps

— 20% of patients were on their way to remission

Overheard in Medicine: Pandemic Wounds Reopened

Overhead in Medicine is a Medscape digest that surfaces a few of the week’s top posts from major medical subreddits.

Tenax Heart Drug Fails to Improve Walking Results in Study, Shares Plunge

Tenax Therapeutics said on Monday its experimental drug did not significantly improve how far patients could walk compared with ⁠placebo in a late-stage trial for a...

Ivacaftor Boosts Height and Lung Function in Cystic Fibrosis

Children and young adults with cystic fibrosis, especially those with severe CFTR variants, who receive ivacaftor have improved height and lung capacity than peers who do not receive ivacaftor.

Housing Aid Linked to Better NSCLC Survival

Housing assistance was associated with lower mortality among older adults with NSCLC, but the survival advantage was not explained by differences in guideline-concordant treatment.

More Bronchiectasis Patients Benefit From HEMT

Data from the US Bronchiectasis and NTM Research Registry show improvements in cough and exacerbations with highly effective modulator therapy.

Integrating Evolving IO Strategies in Frontline mNSCLC Management

Integrating Evolving IO Strategies in Frontline mNSCLC Management

Case Report: Paradoxical Bronchoconstriction with Short-Acting Beta Agonist

Clinicians perform pulmonary function tests to find the cause

Recommended News For You

Smart exercise planning could boost recovery for people with cancer

According to research, hospitals can save money and help cancer patients by implementing a basic intervention.

Timely ‘Nudges’ Help Spur Talks on Patient Care Goals

High Success Rate With Conversion Therapy for Unresectable Gastroesophageal Cancer

GLP-1 Drugs Linked to Lower Colorectal Cancer Risk for Diabetes Patients.

For relapsed or resistant DLBCL, odronextamab produced positive results.

Decoding calcifications in breast cancer: Towards personalized medicine

Recommended Articles For You

Engineering the Future of Oncology with CAR- Natural Killer Cell Design & Therapeutics 

Targeting BRAF V600E in mCRC: FOLFOX, Cetuximab & Encorafenib Strategies 

Mast Cell-Tumor Cell Interactions in OSCC: Genetic and microRNA Insights 

Unlocking the Mystery of Ovarian Cancer Staging 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Living near St. Louis-area Coldwater Creek during childhood linked with higher risk of cancer from radiation

2.

Cancer during young adulthood carries long-term mental toll, study finds

3.

Glioma Outcomes Shaped by Subtype More Than Tx Sequence

4.

Massachusetts nurses with brain tumors: Department of Public Health 'in communication' with Newton-Wellesley

5.

Whole Foods Recall; RFK Jr.'s Voting Problem; Glass Particles in Biosimilar

1.

Navigating the Stages of Thyroid Cancer: A Guide for Patients

2.

Understanding Hidrocystoma: Symptoms, Causes, and Treatment Options 

3.

The Science Behind Thrombolytic Drugs and Their Benefits 

4.

Clinical Pharmacology of Hypoxia-Activated Anticancer Prodrugs

5.

Does Lactate Signal Anemia? Exploring the Complexities of Hyperlactatemia and Red Blood Cell Health

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII

2.

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

3.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

4.

Blood Clotting Disorders Explained

5.

Efficient Management of First line ALK-rearranged NSCLC - Part VIII


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot